𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcome of Locoregional Therapy for Hepatocellular Carcinoma (HCC) Before Liver Transplantation

✍ Scribed by El-Gazzaz, Galal ;Ibarra, Rafael A. ;Sanabria, Juan ;Menon, KV Narayanan ;Miller, Charles M. ;Fung, John J. ;Aucejo, Federico N.

Book ID
122270115
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
107 KB
Volume
140
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reply: Role of locoregional therapy for
Reply: Role of locoregional therapy for hepatocellular carcinoma before liver transplantation: Answer or myth?
✍ Paige Porrett; Abraham Shaked; Kim Olthoff πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 34 KB πŸ‘ 1 views

Huo and colleagues 1 appropriately note that the low complete response rate to radiofrequency ablation (RFA) in our study contrasts markedly with much of the published literature. Their surprise regarding this finding originates from the commonly held belief that RFA effectively ablates hepatocellul

Treatment of hepatocellular carcinoma in
Treatment of hepatocellular carcinoma in cirrhosis: Locoregional therapies for bridging to liver transplant
✍ Fred T. Lee Jr. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 1 views

Hepatocellular carcinoma (HCC) in the setting of cirrhosis continues to increase in both the United States and abroad because of the widespread incidence of hepatitis B and C. Before the advent of transplantation, liver resection was the only method to achieve cure. However, resection is associated